Also, melanoma cells that had previously developed resistance to MAPK inhibition responded to chemical enforcement of the KDM5B phenotype supporting the observation that chronically drug-resistant melanoma cell populations re-establish normal KDM5B heterogeneity after initial KDM5B enrichment (Fig. 2f and Supplementary Fig. 6d–g). This evidence concerns the gene KDM5B and melanoma.